Annual SG&A
$12.24 M
+$585.00 K+5.02%
31 December 2023
Summary:
Compass Therapeutics annual selling, general & administrative expenses is currently $12.24 million, with the most recent change of +$585.00 thousand (+5.02%) on 31 December 2023. During the last 3 years, it has fallen by -$665.00 thousand (-5.15%). CMPX annual SG&A is now -5.15% below its all-time high of $12.91 million, reached on 01 December 2020.CMPX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.63 M
-$1.09 M-23.17%
01 September 2024
Summary:
Compass Therapeutics quarterly selling, general & administrative expenses is currently $3.63 million, with the most recent change of -$1.09 million (-23.17%) on 01 September 2024. Over the past year, it has increased by +$532.00 thousand (+17.19%). CMPX quarterly SG&A is now -31.45% below its all-time high of $5.29 million, reached on 01 September 2020.CMPX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.33 B
-$47.76 M-3.72%
01 September 2024
Summary:
Compass Therapeutics TTM selling, general & administrative expenses is currently -$1.33 billion, with the most recent change of -$47.76 million (-3.72%) on 01 September 2024. Over the past year, it has dropped by -$1.34 billion (-10966.08%). CMPX TTM SG&A is now -991.17% below its all-time high of $14.56 million, reached on 01 September 2024.CMPX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.0% | +17.2% | -10000.0% |
| 3 y3 years | -5.2% | +34.3% | -10000.0% |
| 5 y5 years | +9.2% | +50.9% | -10000.0% |
CMPX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.2% | +12.0% | -23.2% | +34.3% | -78.4% | at low |
| 5 y | 5 years | -5.2% | +12.0% | -31.4% | +74.0% | -991.2% | at low |
| alltime | all time | -5.2% | +12.0% | -31.4% | +74.0% | -991.2% | at low |
Compass Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.63 M(-23.2%) | $14.56 M(+3.8%) |
| June 2024 | - | $4.72 M(+45.4%) | $14.03 M(+12.9%) |
| Mar 2024 | - | $3.25 M(+9.5%) | $12.42 M(+1.4%) |
| Dec 2023 | $12.24 M(+5.0%) | $2.97 M(-4.1%) | $12.25 M(+0.1%) |
| Sept 2023 | - | $3.10 M(-0.6%) | $12.24 M(+2.4%) |
| June 2023 | - | $3.11 M(+1.3%) | $11.95 M(-0.1%) |
| Mar 2023 | - | $3.07 M(+3.8%) | $11.96 M(+2.6%) |
| Dec 2022 | $11.66 M(+6.7%) | $2.96 M(+5.5%) | $11.66 M(-3.9%) |
| Sept 2022 | - | $2.81 M(-10.2%) | $12.13 M(+0.9%) |
| June 2022 | - | $3.13 M(+12.9%) | $12.02 M(+8.7%) |
| Mar 2022 | - | $2.77 M(-19.3%) | $11.06 M(+1.2%) |
| Dec 2021 | $10.93 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $3.43 M(+26.9%) | $10.93 M(-1.1%) |
| Sept 2021 | - | $2.70 M(+24.7%) | $11.04 M(-19.0%) |
| June 2021 | - | $2.17 M(-17.8%) | $13.64 M(+0.6%) |
| Mar 2021 | - | $2.63 M(-25.6%) | $13.55 M(+2.8%) |
| Dec 2020 | $12.91 M(+11.2%) | $3.54 M(-33.0%) | $13.18 M(+3.5%) |
| Sept 2020 | - | $5.29 M(+153.8%) | $12.73 M(+29.3%) |
| June 2020 | - | $2.08 M(-7.7%) | $9.85 M(-10.9%) |
| Mar 2020 | - | $2.26 M(-27.1%) | $11.05 M(+25.7%) |
| Dec 2019 | $11.60 M(+3.4%) | $3.10 M(+28.9%) | $8.79 M(+54.5%) |
| Sept 2019 | - | $2.40 M(-26.8%) | $5.69 M(+73.2%) |
| June 2019 | - | $3.28 M | $3.28 M |
| Dec 2018 | $11.22 M | - | - |
FAQ
- What is Compass Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Compass Therapeutics?
- What is Compass Therapeutics annual SG&A year-on-year change?
- What is Compass Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Compass Therapeutics?
- What is Compass Therapeutics quarterly SG&A year-on-year change?
- What is Compass Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Compass Therapeutics?
- What is Compass Therapeutics TTM SG&A year-on-year change?
What is Compass Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of CMPX is $12.24 M
What is the all time high annual SG&A for Compass Therapeutics?
Compass Therapeutics all-time high annual selling, general & administrative expenses is $12.91 M
What is Compass Therapeutics annual SG&A year-on-year change?
Over the past year, CMPX annual selling, general & administrative expenses has changed by +$585.00 K (+5.02%)
What is Compass Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of CMPX is $3.63 M
What is the all time high quarterly SG&A for Compass Therapeutics?
Compass Therapeutics all-time high quarterly selling, general & administrative expenses is $5.29 M
What is Compass Therapeutics quarterly SG&A year-on-year change?
Over the past year, CMPX quarterly selling, general & administrative expenses has changed by +$532.00 K (+17.19%)
What is Compass Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of CMPX is -$1.33 B
What is the all time high TTM SG&A for Compass Therapeutics?
Compass Therapeutics all-time high TTM selling, general & administrative expenses is $14.56 M
What is Compass Therapeutics TTM SG&A year-on-year change?
Over the past year, CMPX TTM selling, general & administrative expenses has changed by -$1.34 B (-10966.08%)